Understanding how HCV exosomes affect liver health
Role of HCV exosomes in intercellular communication
This study is looking at how tiny particles called exosomes from liver cells infected with hepatitis C might contribute to liver scarring, which can lead to serious problems like liver cancer, and it aims to find new ways to help people with chronic hepatitis C avoid or lessen this scarring.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10932668 on NIH RePORTER |
What this research studies
This research investigates the role of exosomes released from hepatitis C virus (HCV)-infected liver cells in promoting liver fibrosis, a serious condition that can lead to liver cancer. By examining how these exosomes communicate with other liver cells, the study aims to uncover the mechanisms that drive liver damage and fibrosis. The research involves both laboratory experiments and animal models to identify key molecules involved in exosome secretion and their effects on liver cell behavior. Ultimately, the goal is to explore potential therapies that could prevent or reduce liver fibrosis in patients with chronic HCV infection.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic hepatitis C infection who are at risk of developing liver fibrosis or cancer.
Not a fit: Patients who do not have hepatitis C or those with advanced liver disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent liver fibrosis and reduce the risk of liver cancer in patients with hepatitis C.
How similar studies have performed: Previous research has shown that targeting exosome communication in other diseases can lead to significant therapeutic advancements, suggesting potential for success in this area as well.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Hahn, Young S. — University of Virginia
- Study coordinator: Hahn, Young S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.